A Phase 2 Study of Decitabine in Combination With Midostaurin (PKC412) for Elderly Patients With Newly Diagnosed FLT3-ITD/TKD Positive Acute Myeloid Leukemia
Phase of Trial: Phase II
Latest Information Update: 09 Sep 2018
At a glance
- Drugs Decitabine (Primary) ; Midostaurin (Primary)
- Indications Acute myeloid leukaemia
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 25 May 2018 Status changed from recruiting to discontinued due to accrual factor.
- 16 Nov 2017 Status changed from active, no longer recruiting to recruiting.